The O-linked N-acetylglucosamine (O-GlcNAc) modification of serine or threonine hydroxyl group is a dynamic, post-translational process mediated by two evolutionally conserved enzymes: O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), which add or remove O-GlcNAc, respectively. This process modifies and regulates more than 600 proteins. Deregulation of this process is involved in various human diseases including diabetes mellitus, cancer, and neurodegenerative diseases. One common signature of neurodegenerative diseases is the formation of protein aggregates, which lead to neuronal degeneration and death. Ectopically expressing aggregate-prone human proteins in C. elegans neurons or muscles provides a whole and simple model organism for studying these complicated diseases. The transparency of the worm allows real-time observation of protein aggregates in live animals. And the short life span of C. elegans makes it more feasible to investigate the effects of aging on neurodegeration. Null mutants of OGT or OGA in C. elegans are viable and fertile, compared to lethal in mammals, making it a good model system to investigate the effects of deregulation of O-GlcNAc modification in C. elegans neurodegenerative models. Proteotoxicity in different C. elegans models was compared in wild type,
ogt-1 mutant, or
oga-1 mutant background. We found that the
ogt-1 mutation alleviated and the
oga-1 mutation enhanced the toxicity of aggregate-prone proteins such as FTDP-17 Tau, beta amyloid, and polyglutamine (polyQ). Furthermore, the enhanced proteotoxicity of polyQ found in
oga-1 mutants was reversed by
ogt-1 mutation, indicating that absence of O-GlcNAc modification leads to reduction of the aggregate-associated proteotoxicity. Our data also showed elevated proteasome activity in
ogt-1 mutants, suggesting a faster turnover of the protein aggregates accounts for the phenotypic alleviation observed in this background. The regulation of O-GlcNAc modification of another protein quality control pathway, autophagy, is currently under investigation. These results indicate that OGT and OGA counteract each other in regulating proteotoxicity in multiple neurodegenerative disease models, and regulation of protein quality control pathways by O-GlcNAc modification could be the underlying mechanism.